Human genomic biomarker RTqPCR array for optimised and mechanistically-based genotoxicity assessment |
GENOMARK |
May 1, 2014 |
December 31, 2018 |
Risk and health impact assessment , Transversal activities in applied genomics |
toxicogenetics , transcriptomics , DNA damage , genotoxicity tests , gene expression profiling , in vitro , 3R , alternative method |
OIE Laboratory Twinning project for foot-and-mouth disease diagnostic laboratory capacity building in Nigeria |
OIE Twinning FMD |
May 1, 2014 |
April 30, 2018 |
Exotic and vector-borne diseases |
foot-and-mouth disease , disease control , diagnostics , staff training , quality control , biosafety , Nigeria |
Protective Effect of South African Plants on Mycotoxin-Induced Mutagenicity and Toxicity |
Z.-Afrika |
April 1, 2014 |
February 28, 2018 |
Risk and health impact assessment |
Mycotoxin , mutagenicity , antimutagenicity , Vitotox test , comet assay , micronucleus test |
Modeling the absorption of cadmium in leaf and root crops |
FoodCad |
March 1, 2014 |
February 29, 2016 |
Trace elements and nanomaterials , Organic contaminants and additives |
cadmium , spinach , carrots , modeling , root uptake |
Development of a prioritisation strategy for hazard characterisation of substances migrating from printed paper and board food contact materials based on their genotoxicity |
PRIMISTRA |
February 17, 2014 |
February 14, 2018 |
Risk and health impact assessment , Organic contaminants and additives |
food contact materials , printing inks , paperboard , genotoxicity , gene mutation , in silico , in vitro , 3R |
Expert Support for the assessment of applications for certificates of conformity, the monitoring of technological developments and research into health effects on wireless technology |
LNE-2014-2022 |
February 3, 2014 |
June 30, 2024 |
Risk and health impact assessment |
mobile phone , radiofrequency radiation , non ionising radiation , biological effects , in vitro , in vivo |
Cancer Control |
CanCon |
February 1, 2014 |
March 1, 2017 |
Cancer centre |
cancer , cancer control |
A 12-years trend analysis of candidemia in Belgium: incidence, drug resistance and antifungal consumption |
CglabrataR |
January 1, 2014 |
June 30, 2018 |
Mycology and aerobiology , Healthcare-associated infections and antimicrobial resistance |
candidemia , antifungal resistance , antifungal consumption , nosocomial diseases , yeast , fungi , mycology |
Antigenic drift in the surface proteins of the mumps virus and its impact on vaccine efficacy |
Bofvax |
January 1, 2014 |
December 31, 2018 |
Viral diseases |
Mumps , vaccination , virus-neutralisation test , immunity , T cell , B cell , epitopes , antigenicity |
Outbreak Support Team |
OST |
November 21, 2013 |
|
Healthcare-associated infections and antimicrobial resistance |
outbreak support team , OST , multidrug resistant organisms , MDRO , antibiotic resistance , chronic care institution , residential care center , ziekenhuis , infection prevention and control , IPC |
Development of an integrated approach based on validated and standardised methods to support the implementation of the EC recommendation for a definition of nanomaterial |
NanoDefine |
November 1, 2013 |
October 31, 2017 |
Trace elements and nanomaterials |
nanomaterials , EC definition , TEM , dispersion protocols , software validation |
Tick-borne encephalitis virus eco-epidemiology: study of the prevalence and pathogenesis in rodents and wild animals |
TBEV Epi |
October 1, 2013 |
December 31, 2019 |
Viral diseases , Epidemiology of infectious diseases , Quality of vaccines and blood products |
tick-borne encephalitis virus , ticks , sentinel , seroprevalence , rodents |
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe |
ADVANCE |
October 1, 2013 |
September 30, 2018 |
Epidemiology of infectious diseases , Quality of vaccines and blood products |
vaccination , immunisation , preventive , therapeutical , pharmacovigilance , epidemiology , surveillance , risk/benefit assesment , patients |
Use of proteomics for the quality control of intravenous immunoglobulins |
PLPROT |
October 1, 2013 |
September 30, 2017 |
Quality of vaccines and blood products |
proteomics , quality control , immunoglobulins , plasma derivatives |
Improvement of anti-TB treatment by study of antibiotic resistance mechanisms |
TB drugs |
June 24, 2013 |
|
Bacterial diseases |
mycobacterium tuberculosis , antibiotic resistance , genetic changes , protein structure , mutants , DNA sequencing |
A common European approach to the regulatory testing of Manufactured Nanomaterials |
NANoREG |
March 1, 2013 |
February 28, 2017 |
Trace elements and nanomaterials |
nanomaterials , EC definition , TEM , inter laboratory comparison , SOP validation |
The Orphanet Encyclopedia, Terminology and Website in Dutch |
OrphaDutch |
January 1, 2013 |
|
Health services research |
rare diseases and disorders , orphan drugs , world wide web , accessibility of Health Services , terminology , Snomed-CT , nomenclature , disease coding |
Virus-host interplay at the early stages of infection |
BELVIR |
October 1, 2012 |
September 30, 2017 |
Trace elements and nanomaterials |
myxoviruses , glycoproteins , TEM , attachment-fusion , mucus , GFP |
Food contaminants |
CONTAM |
July 2, 2012 |
June 30, 2024 |
|
food contaminants , risk assessment , consumer exposure |
Bioavailability and transformation of arsenic from food: role of food preparation, preservation and digestion |
BIOTRAs |
February 1, 2012 |
January 31, 2015 |
Trace elements and nanomaterials |
arsenic , speciation , bioaccessibility , risk evaluation , exposure , food preparation |
Clinical validation of human papillomavirus assays (VALGENT) |
VALGENT |
January 15, 2012 |
|
Cancer centre |
Human papillomavirus , cervical cancer , cervical cancer screening , diagnostic test accuracy , test validation , quality control |
Communication with communities |
Communication with communities |
January 2, 2012 |
|
Infectious diseases in humans , Laboratory of medical microbiology (LMM) |
Laboratory , Medical Microbiology , Belgian Communities , infectious diseases , medical advice , logistical support , sample management , data on infectious diseases |
Severe Acute Respiratory Infection surveillance by a sentinel network of hospitals |
SARI |
January 1, 2012 |
|
Viral diseases , Epidemiology of infectious diseases |
SARI surveillance , severe acute respiratory infections , sentinel , Influenza |
Central Registry Rare Diseases |
CRRD |
January 1, 2012 |
|
Health services research |
patient registry , rare diseases , epidemiology , genetic centre , ORPHA-code , Healthdata.be , clinical trial recruitment , common data set |
European Surveillance of Antimicrobial Consumption Network |
ESAC-Net |
November 30, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
surveillance , antimicrobial consumption , community , hospital |
Clinical Biology LMM |
LMM |
June 1, 2011 |
|
Infectious diseases in humans , Laboratory of medical microbiology (LMM) |
Laboratory , Medical Microbiology , clinical biology , test validation , quality control , communication improvement , clinical relevance optimisation , medical collaboration , medical contacts , Belgian Communities , medical expert advice |
Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals |
ECDC-PPS |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
nosocomial infection , healthcare-associated infection , antibiotics , acute hospitals |
Belgian Treatment Demand Indicator Register |
BTDIR |
January 1, 2011 |
|
Health information |
|
National Reference Laboratory/Centre for Rabies: surveillance and diagnosis of rabies in man and animal |
NRL/NRC Rabies |
January 1, 2011 |
|
Viral diseases |
rabies , lyssavirus , bats , diagnosis , serology , surveillance |
Quality indicators for infection prevention and control in acute hospitals |
NSIH_QI |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
quality indicators , infection prevention and control , acute hospitals |